Cargando…
Intrathecal Ziconotide and Morphine for Pain Relief: A Case Series of Eight Patients with Refractory Cancer Pain, Including Five Cases of Neuropathic Pain
INTRODUCTION: Studies have shown that, at low doses and with careful titration, combination therapy with intrathecal ziconotide and morphine results in rapid control of opioid-refractory cancer pain. However, there is a lack of published data regarding the efficacy and safety of intrathecal ziconoti...
Autores principales: | de la Calle Gil, Ana Bella, Peña Vergara, Isaac, Cormane Bornacelly, María Auxiliadora, Pajuelo Gallego, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685866/ https://www.ncbi.nlm.nih.gov/pubmed/26563119 http://dx.doi.org/10.1007/s40120-015-0035-z |
Ejemplares similares
-
Intrathecal Therapy for Chronic Pain: A Review of Morphine and Ziconotide as Firstline Options
por: Deer, Timothy R, et al.
Publicado: (2019) -
Intrathecal pain management with ziconotide: Time for consensus?
por: Matis, Georgios, et al.
Publicado: (2021) -
Safety and efficacy of intrathecal ziconotide in the management of severe chronic pain
por: Smith, Howard S, et al.
Publicado: (2009) -
Intrathecal Ziconotide: Dosing and Administration Strategies in Patients With Refractory Chronic Pain
por: McDowell, Gladstone C., et al.
Publicado: (2016) -
Near-resolution of persistent idiopathic facial pain with low-dose lumbar intrathecal ziconotide: a case report
por: Staub, Brandon P, et al.
Publicado: (2019)